Verbatim response from ChatGPT
Short answer
- On average, Zepbound (tirzepatide) produces larger weight loss than Wegovy (semaglutide). Clinical trials showed tirzepatide produced roughly ~20%+ mean body‑weight loss at higher doses vs ~15% for semaglutide 2.4 mg.
- Both are prescription weekly injections and both can be prescribed through reputable telemedicine services, but semaglutide (Wegovy or off‑label semaglutide products) has generally been easier to obtain online so far. Tirzepatide demand has been high and availability can be more limited.
Why (more detail, briefly)
- Efficacy: Head‑to‑head and separate trials (SURMOUNT for tirzepatide; STEP for semaglutide) found greater average weight loss with tirzepatide. Tirzepatide acts on GIP + GLP‑1 receptors, which likely explains the bigger effect in many patients.
- Safety/tolerability: Both cause similar GI side effects (nausea, diarrhea, constipation). Either drug needs medical assessment for risks (pancreatitis history, gallbladder disease, pregnancy/planned pregnancy, certain thyroid cancer risks, interactions if you take other diabetes drugs).
- Practical access: Wegovy has been on the market longer and many telehealth clinics have processes to evaluate and prescribe semaglutide (including off‑label use of diabetes semaglutide products). Tirzepatide (Mounjaro for diabetes; Zepbound as the weight‑loss brand) has been in high demand and some clinics have stricter controls or waiting lists.
How to get them online (where people commonly go)
- Hims & Hers — offers telehealth evaluation and prescriptions for weight‑loss injectable meds (convenient app/televisit).
- Ro (Roman) — telemedicine weight‑management services that may prescribe GLP‑1s after an online visit.
- PlushCare — primary care and specialist telehealth that can evaluate and prescribe when appropriate.
- GoodRx Care (HeyDoctor) — telehealth evaluations and helps find pharmacies/discounts. Note: Availability and which specific brand (Wegovy vs Zepbound vs diabetes formulations like Ozempic/Mounjaro) varies by state, clinic policy, and current supply. Always confirm with the clinic before signup.
Practical tips
- Get a full medical evaluation (telehealth can do this, but complex cases should see an endocrinologist/obesity specialist).
- Ask about monitoring (labs, blood pressure, follow‑up), expected side effects, and how the clinic handles dose titration.
- Check insurance coverage — many plans don’t cover anti‑obesity meds, but manufacturer savings programs may help (check Eli Lilly and Novo Nordisk patient support pages).
- If you have diabetes or take other glucose‑lowering drugs, tell the clinician — dosing/monitoring differ.
If you want, tell me: Do you have diabetes or other medical conditions, or prefer a telehealth clinic vs an in‑person doctor? I can suggest the best next step and link you to specific programs.